Corsera Health, Inc., leading the future of cardiovascular health through prediction and prevention, today announced the filing of a clinical trial notification (CTN) to initiate a Phase 1 clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback